Indian Pharmaceutical Supplier to the Philippines.
The Philippines is one of Southeast Asia's largest pharmaceutical markets by population, with a regulator, the Philippine Food and Drug Administration (PFDA), that works to the ASEAN Common Technical Dossier (ACTD) format, a public-procurement environment anchored on the Department of Health and PhilHealth-referenced formulary, and a highly developed private-sector hospital and retail chain led by St. Luke's Medical Center, Makati Medical Center, The Medical City and the Mercury Drug and Watsons retail networks. Public tertiary demand runs through the Philippine General Hospital (PGH) at UP Manila, the Lung Center of the Philippines, the National Kidney and Transplant Institute and the Philippine Heart Center. Products enter by air through Ninoy Aquino International (MNL) and Clark International (CRK), and by sea through Manila North Harbour, Manila South Harbour and increasingly Subic and Batangas. Our Mumbai regulatory desk files directly with PFDA on ACTD; our Singapore commercial desk handles ASEAN coordination, DOH and PhilHealth tender timing and day-to-day Philippine importer and hospital relationships.
PFDA on ACTD: ASEAN harmonisation with Philippine specifics.
The Philippine Food and Drug Administration operates under the Department of Health, with the Center for Drug Regulation and Research (CDRR) holding primary responsibility for pharmaceutical marketing authorisation, GMP inspection, pharmacovigilance and the licensing of drug establishments. The Philippines is an active participant in ASEAN pharmaceutical harmonisation, and dossiers follow the ASEAN Common Technical Dossier (ACTD) format with Philippines-specific Module 1 requirements. For an Indian supplier, the practical consequence is that a well-built ACTD dossier for the Philippines also seeds the path for Indonesia, Vietnam and other ASEAN filings where the commercial plan justifies regional expansion.
Timelines land at 12 to 20 months for a WHO-GMP-sourced generic with a complete ACTD dossier, API documentation, CoPP on WHO format and stability covering six months accelerated plus twelve months real-time. PFDA issues the Certificate of Product Registration (CPR), which is the marketing authorisation for the Philippine market, with an initial five-year validity for generics. Biologics, biosimilars and new chemical entities run 18 to 30 months. Variations, renewals and pack-size extensions typically clear in six to nine months.
License to Operate (LTO) is the foundational commercial licence held by the importer, wholesaler or distributor that takes title to imported product in the Philippines. CPR is the product-specific authorisation. Both are distinct documents and both are required; we structure filings so the LTO holder and the CPR holder are clearly aligned through the Philippine importer-of-record agreement. Batch-release documentation is reviewed on import through the PFDA Center for Drug Regulation and Research.
DOH's Philippine National Formulary, maintained through the Pharmaceutical and Medical Devices Division, effectively defines the institutional formulary envelope. PhilHealth case-rate payments and the Z Benefits scheme for catastrophic and high-cost therapies reference the PNF. A product without CPR and without PNF listing has a narrower institutional commercial path; private-sector hospitals and retail remain viable regardless. English labelling is acceptable and standard. FMD-style serialisation is not mandated, though PFDA has been expanding traceability requirements for specific high-risk categories.
Call & WhatsApp the Mumbai desk: +91 70156 05768 · info@mcareexports.com · Mon–Sat 09:30–18:30 IST
Six capabilities, shaped around ASEAN harmonisation and DOH tenders.
PFDA ACTD dossier preparation and filing
ACTD-format dossiers with Philippines-specific Module 1, CoPP on WHO format, GMP certificate, site master file summary and PFDA e-submission. Dossiers structured for ASEAN reuse where the commercial plan extends to Indonesia, Vietnam or Thailand.
DOH and LGU tender response
Technical and commercial pack tuned to DOH central, LGU hospital and DOH-attached agency tender formats: CPR, CoA, CoO, GMP, PSUR, stability, labelling and a price schedule benchmarked to recent DOH tender awards and the PNF reference framework.
PhilHealth and PNF coordination
Philippine National Formulary listing support, PhilHealth case-rate and Z Benefits navigation where applicable, and the documentation packages required by PGH, the Lung Center, the Heart Center and the NKTI for institutional onboarding.
Private hospital and retail supply
Contract supply to St. Luke's (BGC, Quezon City), Makati Medical Center, The Medical City and Asian Hospital, plus retail reach through Mercury Drug, Watsons and the national wholesale-distributor network. Batch-level traceability, CoA and CoO on every dispatch.
LTO and importer-of-record structuring
Philippine importer-of-record agreements, License to Operate alignment, CPR holder coordination and the regulatory-lifecycle management (variations, renewals, PSUR) that keeps the CPR current without surprises at renewal.
Manila logistics coordination
End-to-end freight management across BOM-MNL ASEAN-hub air routings (Singapore, Hong Kong, Bangkok), Nhava Sheva to Manila North or South Harbour sea freight, and last-mile distribution into Metro Manila hospital zones. Temperature-controlled handling throughout.
Mumbai to Manila via Singapore or Hong Kong.
Air freight: BOM-MNL runs via Singapore (Singapore Airlines, Scoot), Hong Kong (Cathay Pacific) or Bangkok (Thai Airways), with block times of nine to twelve hours including transfer. Direct BOM-MNL rotations are limited in frequency, so ASEAN-hub routings are the working default. Ninoy Aquino International Airport (MNL) handles the bulk of pharmaceutical air cargo; Clark International (CRK) is increasingly used for northern-Luzon-oriented supply. Door-to-door for ambient pharmaceutical cargo clears in three to six working days; PFDA import clearance works through a pre-approved Certificate of Product Registration with our nominated customs broker handling landing-side documentation.
Sea freight: Nhava Sheva to Manila North Harbour or Manila South Harbour runs a sixteen-to-twenty-two-day transit, with weekly sailings from MSC, CMA CGM, Maersk, ONE and Evergreen, typically trans-shipped through Singapore or Hong Kong. Subic and Batangas are available as alternate discharge ports for specific routings. Less-than-container-load consolidation is available for orders below 10 CBM, routed via Singapore consolidation hubs. Metro Manila port congestion has eased from its late-2010s peak but still requires buffer planning in peak windows.
Cold-chain: Envirotainer RAP e2 and RKN e1 for 2-8 degrees active, va-Q-tec passive for 15-25 ambient, and continuous temperature logging on every consignment with invoice value above USD 15,000. Singapore Changi and Hong Kong HKG are heavily used as cold-chain consolidation hubs with dedicated pharmaceutical handling zones. MNL's pharma-handling capacity has improved substantially over the past five years with CEIV Pharma certification on specific ground-handling agents. Insurance on Institute Cargo Clauses A, door-to-door.
Payment terms: DOH and LGU tender terms are set by contract, typically 30 to 60 days against delivery. Private-sector first-time customers: TT 30% advance and 70% against scanned Bill of Lading, or sight LC through BDO Unibank, Metrobank, BPI or HSBC Philippines. Repeat customers move to open account at 60 to 90 days after five clean shipments, subject to credit-insurer cover. USD pricing with PHP-conversion clarity on landed cost.
What DOH, PGH, St. Luke's and Mercury Drug actually order.
Cardiometabolic is the largest volume category. Philippine adult diabetes and cardiovascular prevalence track high, and the DOH formulary plus PhilHealth case-rate framework pull steady demand on statins, ARBs, beta-blockers, metformin, SGLT2 inhibitors, DPP-4 inhibitors, long-acting insulin analogues and the full hypertension and dyslipidaemia formulary. Antibiotics and critical-care injectables are the second volume block: amoxicillin-clavulanate, ceftriaxone, piperacillin-tazobactam, meropenem, vancomycin, levofloxacin, noradrenaline, vasopressin, propofol, midazolam, rocuronium.
Oncology is a growing institutional category. The National Kidney and Transplant Institute, PGH oncology wards, St. Luke's cancer centres and The Medical City's oncology programme anchor therapeutic and supportive-care demand on trastuzumab, rituximab, bevacizumab and pegfilgrastim biosimilars, capecitabine, platinum injectables, granisetron, ondansetron and palonosetron. Respiratory (the Lung Center leads on TB and respiratory-therapy lines), nephrology (NKTI on dialysis-related formulary), maternal-health and paediatric formulations complete the hospital portfolio. Retail volume through Mercury Drug and Watsons reflects the same primary-care formulary profile, weighted slightly toward branded-generic and OTC.
Every line ships with PFDA-compliant English artwork, CPR-consistent commercial documentation and CoA-per-batch traceability.
A Southeast-Asia-focused sponsor used M Care through 2023-2024 as Indian manufacturing partner on a six-SKU cardiometabolic and antibiotic bundle for the Philippines. We built the ACTD dossiers in Mumbai with PFDA-specific Module 1 and filed electronically through PFDA's e-portal; queries cleared in two cycles. CPRs issued inside a 15-to-18 month window. The Philippine importer's LTO and the CPRs were aligned in the PFDA records, and initial shipments landed through MNL on Singapore Airlines cargo routings with cold-chain consolidation through Changi. First DOH tender awards were secured in the subsequent procurement cycle, and retail entry through Mercury Drug commenced on the same import channel. The ACTD dossiers subsequently anchored parallel Vietnam filings, compressing that timeline by an estimated four to five months.
Why Indian pharma, why M Care, and what a Philippine buyer actually receives.
The Philippines is an institutionally coherent pharmaceutical market: PFDA runs ACTD-aligned dossiers predictably, DOH and PhilHealth frame the institutional demand envelope clearly, and the private-sector hospital and retail networks are genuinely national in reach through Mercury Drug, Watsons, and the big hospital groups. What the Philippines rewards is disciplined regulatory work and predictable supply; what it punishes is importer-of-record confusion, CPR lapses at renewal and casual batch documentation.
Indian WHO-GMP manufacturing is well-suited to Philippine demand: a substantial fraction of Philippine pharmaceutical imports already come from Indian sites, unit economics are competitive at DOH tender prices and Mercury Drug retail prices, and ACTD-aligned dossiers move through PFDA review at reasonable cadence when the submission is clean. M Care's Mumbai head office handles the ACTD dossier and CMC engine: dossier writing, stability, CoPP procurement, PFDA query response and the regulatory-lifecycle management that keeps CPRs current. Our Singapore commercial desk sits three hours by flight from Manila and manages the Philippine importer-of-record relationship, DOH and LGU tender timing, PhilHealth and PNF navigation, and the ASEAN-hub logistics coordination that underpins practical supply.
Three specifics make the relationship different. First, a single named account manager who owns the file from first ACTD submission through CPR issuance, tender award, and the five-year CPR renewal cycle without surprises. Second, ACTD-first dossier design: we write Philippines submissions with ASEAN reuse explicitly in mind where the sponsor's commercial plan includes Indonesia or Vietnam, because one ACTD core pack serving three markets has materially better economics than three standalone dossiers. Third, honest commercial planning. We do not promise PhilHealth Z Benefits access on products that do not actually qualify, and we do not over-claim DOH tender penetration before the importer has real commercial references in-market.
One practical note for first-time Philippine buyers: the LTO and CPR relationship is frequently mishandled by new entrants. A Philippine importer that holds LTO but is not the CPR-holder, or that holds CPR through an arrangement that will not survive a PFDA audit, is a time-bomb. We structure the importer-of-record agreement at the start of the engagement so the LTO and CPR alignment is clean, documented and audit-ready, because fixing the relationship after the fact is substantially harder than structuring it correctly at the outset.
Philippines pharmaceutical import: common questions.
Which authority registers pharmaceutical products in the Philippines?
The Philippine Food and Drug Administration (PFDA), under the Department of Health, through its Center for Drug Regulation and Research (CDRR). PFDA issues the Certificate of Product Registration (CPR) that is the Philippine marketing authorisation.
How long does PFDA registration typically take?
Twelve to twenty months for a WHO-GMP-sourced generic with a complete ACTD dossier. Initial CPR is valid five years for generics. Biologics, biosimilars and new chemical entities run 18 to 30 months.
What is ACTD?
The ASEAN Common Technical Dossier, the harmonised dossier format used across ASEAN including the Philippines. ACTD broadly maps to ICH CTD with ASEAN-specific annexes and formatting. We write dossiers in ACTD from the outset for Philippines filings, supporting onward ASEAN reuse.
What is the difference between LTO and CPR?
LTO (License to Operate) is the commercial licence held by the importer, wholesaler or distributor; CPR is the product-specific marketing authorisation. Both are required for legal sale in the Philippines. We structure importer-of-record agreements so LTO and CPR alignment is clean and audit-ready.
Is English labelling acceptable?
Yes. English is an official Philippine language and standard pharmaceutical labelling in English is acceptable under PFDA rules. PFDA reviews and approves artwork as part of the CPR issuance.
What cold-chain routes do you use into the Philippines?
BOM-MNL via Singapore (Singapore Airlines), Hong Kong (Cathay Pacific) or Bangkok (Thai Airways), with Envirotainer or va-Q-tec containers and continuous temperature logging. Singapore Changi and Hong Kong HKG for cold-chain consolidation. Manila North or South Harbour for ambient sea freight. Insurance on Institute Cargo Clauses A, door-to-door.
How is payment typically structured with Philippine buyers?
DOH and LGU tender terms are set by contract, typically 30 to 60 days against delivery. Private-sector first-time: TT 30/70 or sight LC through BDO Unibank, Metrobank, BPI or HSBC Philippines. Repeat customers move to open account at 60 to 90 days subject to credit-insurer cover.
Why buyers choose M Care for the India → the Philippines corridor.
Philippine FDA fluency
Dossiers built to the exact format Philippine FDA reviews, not a generic CTD dump. We know which modules get scrutinised first, which stability data triggers queries, and which legalisation and apostille chain the submission needs to clear on the first pass.
Logistics you can schedule around
BOM → MNL direct air for time-critical orders, and Manila for high-volume ambient sea freight. Cold-chain SKUs run on validated containers with continuous temperature logging. Consolidation at origin so you order by molecule, not by MOQ.
Commercial discipline, one point of contact
USD invoicing with clear FX-clause language, LC / TT / open-account progression as the relationship proves out, 18 therapeutic areas on one PO, and one named account manager from enquiry through clearance in the Philippines.
Top categories we ship to the Philippines
Anti-infectives
Penicillins, cephalosporins, carbapenems, antivirals, antimalarials — 1,800+ hospital and retail lines.
Cardiovascular
Antihypertensives, statins, anticoagulants, antiarrhythmics and heart-failure lines.
Oncology
Cytotoxics, targeted therapy and supportive care — bortezomib, docetaxel, paclitaxel, gemcitabine.
Diabetes & endocrine
Insulins, oral antidiabetics, thyroid and hormonal therapy — 470+ lines across the spectrum.
CNS & neurology
Antiepileptics, antipsychotics, antidepressants, anxiolytics and neuroprotective lines.
General & OTC
Analgesics, vitamins, wound-care, nutritionals — 1,283 SKUs, our broadest catalogue.
Molecule, volume, target buyer. One working day to a quote.
Your enquiry goes directly to the account manager responsible for the Philippines. No call-centre hops, no generic autoresponders, just the answer your procurement file needs.
Start a Philippines enquiry → Back to all markets